Navigate the complexities of cell and gene therapies
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Regulatory Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Washington, DC (PRWEB) April 04, 2023 -- NDA Partners’ Vice President and General Manager, Eric Fish, announced today that Dr. Daniela Drago, a senior global
Toronto, ON (PRWEB) April 03, 2023 -- The regulations governing drugs are built on the science employed in the development of these products. Worldwide,
The FDA has accepted for Priority Review the zuranolone NDA for major depressive disorder and postpartum depression.
The FDA has accepted for Priority Review the zuranolone NDA for major depressive disorder and postpartum depression.